Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome

Human Reproduction

Volumn 22, Issue 7, 2007, Pages 1824-1829

  Kowalska, Irina ^a   Straczkowski, Marek ^a   Nikolajuk, Agnieszka ^a   Adamska, Agnieszka ^a   Karczewska Kupczewska, Monika ^a   Otziomek, Elzbieta ^a   Wolczynski, Slawomir ^a   Gorska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hyperandrogenism; Insulin resistance; Polycystic ovary syndrome; Visfatin

Indexed keywords

ANDROGEN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; VISFATIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EQUUS ASINUS;

EID: 34447336403     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem118     Document Type: Article

References (26)

1. Arner P. Insulin resistance in type 2 diabetes-role of adipokines. Curr Mol Med 2005;5:333-339.
2. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon M R, Stumvoll M, Bluher M. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005;54 2911-2916.
3. Chan TF, Chen YL, Lee CH, Chou FH, Wu LC, Jong SB, Tsai EM. Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig 2006;13:364-367.
4. Chen MP, Chung FM, Chang DM, Tsai JCR, Huang H-F, Shin SJ, Lee YJ. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-299.
5. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumie A. Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006;49:744-747.
6. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
7. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-1174,
8. Duncombe WS. The colorimetric microdetermination of nonesterified fatty acids in plasma. Clin Chim Acta 1964;9:122-135.
9. Fernandez-Real JM, Vayreda M. Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001;83:1154-1159.
10. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H et al. Visfatin: A protein secreted by visceral fat that mimics the effect of insulin. Science 2005;307:426-430.
11. Haider DG, Mittermayer F, Schaller G, Artwohl M, Baumgartner-Parzer SM, Prager G, Roden M, Wolzt M. Free fatty acids normalize a rosiglitazone-induced visfatin release. Am J Physiol 2006a;doi:10.1152/ajpendo.00109.2006.
12. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006b;49:1909-1914.
13. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006c;91 1578-1581.
14. Hotamisligil GS, Armer P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95 2409-2415.
15. Krzyzanowska K, Krugkuger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G. Increased plasma visfatin concentrations in women with gestational diabetes mellitus. Clin Sci 2006;111 605-609.
16. Li M, Youngren JF, Dunaif A, Goldfine ID, Maddux BA,Zhang BB, Evans JL. Decreased insulin receptor (IR) autophosphorylation in fibroblast from patients with PCOS: Effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 2002;87:4088-4093.
17. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, Milan G, Rossato M, Federspil G, Vettor R. Reduced plasm visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006;91:365-3170.
18. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97:2859-2865.
19. Stefan N, Vozarowa B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RC, Youngren JF, Havel PJ, Pratley RE, Bogardus C et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine tphosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;51:1884-1888.
20. Steppan CM, Balley ST, Bhaf S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar M. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
21. Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Kinalska I, Baranowski M, Zendzian-Piotrowska M, Brzezinska Z, Gorski J. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004;53:1215-1221.
22. Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS. Increased visfatin mRNA and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome (PCOS): Parallel increase in plasma visfatin. J Clin Endocrinol Metab 2006;doi:10.1210/jc.2006-0828.
23. The Rotherdam ESHRE/ASRM-sponsored PCOS consensus workshop group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome (PCOS). Hum Reprod 19 41-47.
24. Vermeulen A, Verdonck I, Kaufman JM. A critical evaluation of simple method for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
25. Wood IS, Wang B, Jenkins JR, Trayhurn P. The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes. Biochem Biophys Res Commun 2005; 337:422-429.
26. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.